In regards to the topic of Frontier Science, I find the article “Structure-Based Design of
Antiviral Drug Candidates Targeting the SARS-CoV-2 Main Protease” to be relevant and
proactive. To begin with, this article highlights the growing concern of COVID-19 in regards to clinical antiviral treatments; with not enough evidence or valid research thus far, COVID-19
remains a mystery and an even bigger threat. This article represents the possibility of modern development of a COVID-19 clinical treatment by utilizing previous research of SARS-CoV-2. I selected this article for the fact that, although these aspects of COVID-19 are based on previous research of SARS-CoV-2, research regarding COVID-19 remains to be extremely recent as well as controversial. Overall, I find this article interesting as well as eye opening, especially considering the severity of COVID-19 in modern medicine, but also within the minds of the general public.
Cited Research Study
Dai, Wenhao, et al. “Structure-Based Design of Antiviral Drug Candidates Targeting the
SARS-CoV-2 Main Protease.” Science, vol. 368, no. 6497, 2020, pp. 1331–1335.,